Authors:
WOYNAROWSKA B
WOYNAROWSKI JM
HERZIG MCS
ROBERTS K
HIGDON AL
MACDONALD JR
Citation: B. Woynarowska et al., DIFFERENTIAL INDUCTION OF APOPTOSIS IN TUMOR AND NORMAL-CELLS BY 6-HYDROXYMETHYLACYLFULVENE (HMAF), Annals of oncology, 9, 1998, pp. 404-404
Authors:
HERZIG MCS
TREVINO AV
ARNETT BM
WOYNAROWSKI JM
Citation: Mcs. Herzig et al., SITE-SPECIFICITY AND REGION-SPECIFICITY OF TALLIMUSTINE LESIONS IN CELLULAR DNA, Annals of oncology, 9, 1998, pp. 527-527
Authors:
WOYNAROWSKI JM
CHAPMAN WG
NAPIER C
HERZIG MCS
JUNIEWICZ P
Citation: Jm. Woynarowski et al., SEQUENCE-SPECIFICITY AND REGION-SPECIFICITY OF OXALIPLATIN ADDUCTS INNAKED AND CELLULAR DNA, Molecular pharmacology, 54(5), 1998, pp. 770-777
Authors:
HERZIG MCS
NASH NR
CONNOLLY M
KYLE DJ
LEEBLUNDBERG LMF
Citation: Mcs. Herzig et al., THE N-TERMINUS OF BRADYKININ WHEN BOUND TO THE HUMAN BRADYKININ B2 RECEPTOR IS ADJACENT TO EXTRACELLULAR CYS(20) AND CYS(277) IN THE RECEPTOR, The Journal of biological chemistry, 271(47), 1996, pp. 29746-29751
Citation: Mcs. Herzig et Lmf. Leeblundberg, THE AGONIST BINDING-SITE ON THE BOVINE BRADYKININ B2 RECEPTOR IS ADJACENT TO A SULFHYDRYL AND IS DIFFERENTIATED FROM THE ANTAGONIST BINDING-SITE BY CHEMICAL CROSS-LINKING, The Journal of biological chemistry, 270(35), 1995, pp. 20591-20598
Citation: Mcs. Herzig et Lmf. Leeblundberg, THE AGONIST BINDING-SITE ON THE BOVINE BRADYKININ B2-RECEPTOR IS ADJACENT TO A SULFHYDRYL AND DIFFERS FROM THE ANTAGONIST BINDING-SITE, The FASEB journal, 8(7), 1994, pp. 10001320-10001320
Citation: Lmf. Leeblundberg et al., AGONIST AND ANTAGONIST BINDING TO G-PROTEIN-COUPLED B2-KININ RECEPTORS, The FASEB journal, 8(4), 1994, pp. 10000352-10000352
Citation: Lmf. Leeblundberg et al., ANTAGONISTS OF BRADYKININ THAT STABILIZE A G-PROTEIN-UNCOUPLED STATE OF THE B2 RECEPTOR ACT AS INVERSE AGONISTS IN RAT MYOMETRIAL CELLS, The Journal of biological chemistry, 269(42), 1994, pp. 25970-25973